Hýzlý Arama
COVID-19’a Baðlý Diffüz Alveoler Hemoraji: Olgu Sunumu
Gülbahar Darýlmaz Yüce1, Dorina Esendaðlý1, Koray Hekimoðlu2, Merih Tepeoðlu3, Müþerref Þule Akçay11Baþkent Üniversitesi Göðüs Hastalýklarý Anabilim Dalý, Ankara2Baþkent Üniversitesi, Radyoloji Anabilim Dalý, Ankara
3Baþkent Üniversitesi, Týbbi Patoloji Anabilim Dalý, Ankara
Diffüz alveoler hemoraji, öksürük, hemoptizi, yaygýn pulmoner infiltratlar, anemi ve hipoksemik solunum sýkýntýsý ile karakterize bir sendromdur. Etyolojisinde akciðer enfeksiyonlarý da rol oynamaktadýr. Enfeksiyon riski nedeniyle COVID-19 hastalarýnda bronkoskopi kullanýmýnýn kýsýtlanmasý, diffüz alveoler hemorajinin COVID-19’da yeterince tanýnamamasýna neden olmaktadýr. Burada SARS-CoV-2 baðlamýnda laboratuvar, radyolojik ve bronkoskopik olarak diffüz alveoler hemoraji kanýtý olan 35 yaþýndaki hastada SARS-CoV-2 için nasofarengeal sürüntü polymerase chain reaction (PCR) testi negatif saptanmýþ, COVID-19 tanýsý bronþ lavajý ile konulabilmiþtir. Yüksek enfeksiyon riski nedeniyle pandemi döneminde bronkoskopi kullanýmýnýn kýsýtlanmasý, SARS-CoV-2 PCR testi negatif immünsupresif hastalarda COVID-19 tanýsýnýn yanlýþlýkla dýþlanmasýna veya SARS-CoV-2 PCR pozitif hastalarda diffüz alveoler hemoraji ve sekonder enfeksiyon gibi durumlarýn yeterince tanýnamamasýna neden olmaktadýr.
Anahtar Kelimeler: COVID-19, Diffüz alveolar hemoraji, buzlu cam opasitelerCOVID-19-Associated Diffuse Alveolar Hemorrhage: A Case Report
Gülbahar Darýlmaz Yüce1, Dorina Esendaðlý1, Koray Hekimoðlu2, Merih Tepeoðlu3, Müþerref Þule Akçay11Department of Chest Diseases, Baþkent University, Ankara, Türkiye2Department of Radiology, Baþkent University, Ankara, Türkiye
3Department of Medical Pathology, Baskent University, Ankara, Türkiye
Diffuse alveolar hemorrhage is a syndrome characterized by cough, hemoptysis, diffuse pulmonary infiltrates, anemia, and hypoxemic respiratory distress, and lung infections also play a role in its etiology. The restricted use of bronchoscopy in COVID-19 patients due to the risk of infection has led to the poor recognition of diffuse alveolar hemorrhage in COVID-19. We present here the case of a 35-year-old patient with laboratory, radiological and bronchoscopic evidence of diffuse alveolar hemorrhage who was diagnosed with COVID-19 by bronchial lavage. The restrictions on the use of bronchoscopy during the pandemic due to the high risk of infection has led diagnoses of COVID-19 to be mistakenly excluded in immunosuppressive patients with a negative SARS-CoV-2 polymerase chain reaction test, and the under-recognition of conditions such as diffuse alveolar hemorrhage and secondary infection in patients with a positive SARS-CoV-2 PCR.
Keywords: COVID-19, Diffuse alveolar hemorrhage, ground-glass opacitiesOlgunun Görüntü Kesitleri
Sorumlu Yazar: Gülbahar Darýlmaz Yüce, Türkiye
Makale Dili: Ýngilizce